直觉外科公司第四季度业绩超预期，达芬奇手术量增长18%
1月24日，直觉外科公司发布2024年第四季度业绩。财报显示，第四季度营收为24.1亿美元，去年同期为19.3亿美元，市场预期为22.5亿美元；非GAAP摊薄后每股收益为2.21美元，去年同期为1.60美元，市场预期为1.79美元。
全球达芬奇手术同比增长约18%。该公司表示，本季度投放了493套达芬奇手术系统，而去年同期为415套。第四季度的配售包括174套da Vinci 5系统。截至12月31日，直觉外科公司的达芬奇手术系统安装总数为9,902套，同比增长15%。
该公司本季度末的现金、现金等价物和投资为88.3亿美元，比本季度增加了5.21亿美元。
展望：公司预计2025年全年全球达芬奇手术将增长约13%至16%；公司预计2025年毛利率将在净收入的67%至68%之间。
财报发布后，直觉外科公司美股盘后跌超近2%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10